Clinical Trial Update: Pembrolizumab and Chemotherapy Treatment or no Treatment Guided by the Level of TILs in Resected Early-stage TNBC [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial from UNICANCER evaluating pembrolizumab with chemotherapy or no treatment guided by tumor-infiltrating lymphocytes in resected early-st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: UNICANCER | Conditions: Triple-negative Breast Cancer | Phase 2 | Status: RECRUITING